Is Prevas AB (STO:PREV B) Potentially Undervalued?

Prevas AB (STO:PREV B), might not be a large cap stock, but it saw a significant share price rise of over 20% in the past couple of months on the OM. Less-covered, small caps tend to present more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could the stock still be trading at a low price relative to its actual value? Today I will analyse the most recent data on Prevas’s outlook and valuation to see if the opportunity still exists.

View our latest analysis for Prevas

Advertisement

Is Prevas Still Cheap?

Great news for investors – Prevas is still trading at a fairly cheap price according to my price multiple model, where I compare the company's price-to-earnings ratio to the industry average. In this instance, I’ve used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock’s cash flows. I find that Prevas’s ratio of 11.77x is below its peer average of 15.65x, which indicates the stock is trading at a lower price compared to the IT industry. Although, there may be another chance to buy again in the future. This is because Prevas’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company’s shares will likely fall by more than the rest of the market, providing a prime buying opportunity.

Can we expect growth from Prevas?

earnings-and-revenue-growth
OM:PREV B Earnings and Revenue Growth November 30th 2023

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. Though in the case of Prevas, it is expected to deliver a relatively unexciting earnings growth of 9.4%, which doesn’t help build up its investment thesis. Growth doesn’t appear to be a main reason for a buy decision for the company, at least in the near term.

What This Means For You

Are you a shareholder? Even though growth is relatively muted, since PREV B is currently trading below the industry PE ratio, it may be a great time to increase your holdings in the stock. However, there are also other factors such as capital structure to consider, which could explain the current price multiple.

Are you a potential investor? If you’ve been keeping an eye on PREV B for a while, now might be the time to enter the stock. Its future profit outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy PREV B. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed assessment.

So while earnings quality is important, it's equally important to consider the risks facing Prevas at this point in time. While conducting our analysis, we found that Prevas has 1 warning sign and it would be unwise to ignore this.

If you are no longer interested in Prevas, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

MI
mitchell_lawler
mitchell_lawler

The world's in stitches over robots sprinting into walls. I still think they're the answer to our productivity problem.

The world's in stitches over robots sprinting into walls. I still think they're the answer to our productivity problem. cover
87
DE
devon_jd150

What you have missed is that this event happened last year too. Last year the number was 21 seconds. This year it beat Bolt. That's 60% improvement in an year. Now extrapolate this in many axes of work that Robots can come and fill in. The physical productivity and AI boom is just starting.

LE
LeverageIsLovely

I can't pick a company. But I can pick a person. With no doubt that's Musk. Optimus for blue collar productivity increase and xAI for white collar productivity increase. Did anyone dabble with GrokBot here?

Andrew Legget

Great earnings season, but are the earnings real?

Great earnings season, but are the earnings real? cover
At first glance, this was the strongest earnings season in years. But when you look at where the growth actually came from, the story splits into two very different pictures.
85

About OM:PREV B

Prevas

Provides technical solutions in Sweden, Denmark, Finland, and internationally.

Undervalued with excellent balance sheet and pays a dividend.

Advertisement

Weekly Picks

LO
Lou_Basenese
ONCY logo
Lou_Basenese on Oncolytics Biotech ·

The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech

Fair Value:US$3.576.1% undervalued
44 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative
TR
tripledub
Recommended Voice
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$5862.4% undervalued
63 users have followed this narrative
3 users have commented on this narrative
34 users have liked this narrative
TA
Talos
Emerging Author
VOYG logo
Talos on Voyager Technologies ·

The "Landlord of Orbit" – A Deep Value Play Ahead of the Starlab Era

Fair Value:US$385.291.3% undervalued
68 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
IV
Emerging Author
UBER logo
Ivoed on Uber Technologies ·

Uber’s Valuation Depends On Who Captures The Economics Of Driverless Rides

Fair Value:US$11634.8% undervalued
14 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

LU
LunaRodas
SAIC logo
LunaRodas on Science Applications International ·

SAIC | Science Applications International: What They Said vs. What They Did

Fair Value:US$119.247.5% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AN
LOT logo
Anthony_Lee on Lotus Technology ·

Tech and Tradition: Lotus Technology’s Compound Formula in Luxury EVs

Fair Value:US$2.5354.2% undervalued
2 users have followed this narrative
5 users have commented on this narrative
1 users have liked this narrative
EP
DRY logo
Epstein_Research on Dryden Gold ·

Dryden Gold continues to expand & de-risk its flagship Gold Rock project!

Fair Value:CA$173.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28021.3% undervalued
369 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9120.8% overvalued
214 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
JO
John_Eric
Emerging Author
MELI logo
John_Eric on MercadoLibre ·

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$7.31k73.5% undervalued
125 users have followed this narrative
3 users have commented on this narrative
18 users have liked this narrative